AU2020402573A1 - Therapeutic device for cell therapy or cell stimulation - Google Patents
Therapeutic device for cell therapy or cell stimulation Download PDFInfo
- Publication number
- AU2020402573A1 AU2020402573A1 AU2020402573A AU2020402573A AU2020402573A1 AU 2020402573 A1 AU2020402573 A1 AU 2020402573A1 AU 2020402573 A AU2020402573 A AU 2020402573A AU 2020402573 A AU2020402573 A AU 2020402573A AU 2020402573 A1 AU2020402573 A1 AU 2020402573A1
- Authority
- AU
- Australia
- Prior art keywords
- therapeutic device
- electrode
- voltage
- period
- time
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 218
- 230000000638 stimulation Effects 0.000 title claims abstract description 11
- 238000002659 cell therapy Methods 0.000 title claims abstract description 10
- 230000033228 biological regulation Effects 0.000 claims abstract description 7
- 238000002560 therapeutic procedure Methods 0.000 claims description 33
- 239000011521 glass Substances 0.000 claims description 26
- 238000004146 energy storage Methods 0.000 claims description 23
- 238000004364 calculation method Methods 0.000 claims description 19
- 239000003990 capacitor Substances 0.000 claims description 19
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 claims description 19
- 230000007423 decrease Effects 0.000 claims description 17
- 230000008878 coupling Effects 0.000 claims description 14
- 238000010168 coupling process Methods 0.000 claims description 14
- 238000005859 coupling reaction Methods 0.000 claims description 14
- 229920003023 plastic Polymers 0.000 claims description 13
- 239000004033 plastic Substances 0.000 claims description 13
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 claims description 4
- 229910001416 lithium ion Inorganic materials 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 3
- 238000003860 storage Methods 0.000 abstract description 2
- 238000011282 treatment Methods 0.000 description 79
- 210000002381 plasma Anatomy 0.000 description 55
- 238000005259 measurement Methods 0.000 description 54
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 48
- 238000012360 testing method Methods 0.000 description 41
- 210000004027 cell Anatomy 0.000 description 31
- 239000007789 gas Substances 0.000 description 31
- 229920001817 Agar Polymers 0.000 description 28
- 239000008272 agar Substances 0.000 description 28
- 230000006870 function Effects 0.000 description 28
- 230000005764 inhibitory process Effects 0.000 description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 239000011780 sodium chloride Substances 0.000 description 23
- 241000191967 Staphylococcus aureus Species 0.000 description 22
- 241000222122 Candida albicans Species 0.000 description 19
- 241000588724 Escherichia coli Species 0.000 description 18
- 241000191963 Staphylococcus epidermidis Species 0.000 description 18
- 229940095731 candida albicans Drugs 0.000 description 18
- 230000009036 growth inhibition Effects 0.000 description 18
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 17
- 238000004804 winding Methods 0.000 description 17
- 238000010521 absorption reaction Methods 0.000 description 15
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 14
- 238000001228 spectrum Methods 0.000 description 14
- 239000004020 conductor Substances 0.000 description 11
- 244000005700 microbiome Species 0.000 description 11
- 239000002800 charge carrier Substances 0.000 description 10
- 231100000135 cytotoxicity Toxicity 0.000 description 10
- 230000003013 cytotoxicity Effects 0.000 description 10
- 230000003247 decreasing effect Effects 0.000 description 10
- 238000009832 plasma treatment Methods 0.000 description 10
- 241000894007 species Species 0.000 description 10
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 9
- 230000005495 cold plasma Effects 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 229910052754 neon Inorganic materials 0.000 description 8
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 8
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 7
- 230000000845 anti-microbial effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 230000020477 pH reduction Effects 0.000 description 6
- 230000005855 radiation Effects 0.000 description 6
- 229910002651 NO3 Inorganic materials 0.000 description 5
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 5
- 239000012620 biological material Substances 0.000 description 5
- 230000003833 cell viability Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 230000005684 electric field Effects 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 230000003595 spectral effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- 238000001636 atomic emission spectroscopy Methods 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 230000005672 electromagnetic field Effects 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- 239000005022 packaging material Substances 0.000 description 3
- 229920000747 poly(lactic acid) Polymers 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- PKYCWFICOKSIHZ-UHFFFAOYSA-N 1-(3,7-dihydroxyphenoxazin-10-yl)ethanone Chemical compound OC1=CC=C2N(C(=O)C)C3=CC=C(O)C=C3OC2=C1 PKYCWFICOKSIHZ-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- -1 N 20 Inorganic materials 0.000 description 2
- 108090000913 Nitrate Reductases Proteins 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 229910010298 TiOSO4 Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- KADRTWZQWGIUGO-UHFFFAOYSA-L oxotitanium(2+);sulfate Chemical compound [Ti+2]=O.[O-]S([O-])(=O)=O KADRTWZQWGIUGO-UHFFFAOYSA-L 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 230000006950 reactive oxygen species formation Effects 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- QYSWYZJMJYEEGC-UHFFFAOYSA-N 10h-phenoxazine-3,7-diol Chemical compound C1=C(O)C=C2OC3=CC(O)=CC=C3NC2=C1 QYSWYZJMJYEEGC-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 241000935974 Paralichthys dentatus Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000309145 Pseudomonas aeruginosa DSM 50071 = NBRC 12689 Species 0.000 description 1
- LCKIEQZJEYYRIY-UHFFFAOYSA-N Titanium ion Chemical compound [Ti+4] LCKIEQZJEYYRIY-UHFFFAOYSA-N 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000010405 anode material Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001827 electrotherapy Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 150000002826 nitrites Chemical class 0.000 description 1
- 229910052756 noble gas Inorganic materials 0.000 description 1
- 239000000615 nonconductor Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- CENHPXAQKISCGD-UHFFFAOYSA-N trioxathietane 4,4-dioxide Chemical compound O=S1(=O)OOO1 CENHPXAQKISCGD-UHFFFAOYSA-N 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/06—Electrodes for high-frequency therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/44—Applying ionised fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0468—Specially adapted for promoting wound healing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/3603—Control systems
- A61N1/36034—Control systems specified by the stimulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Electrotherapy Devices (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19214663.7 | 2019-12-10 | ||
| EP19214663 | 2019-12-10 | ||
| PCT/EP2020/085655 WO2021116358A1 (de) | 2019-12-10 | 2020-12-11 | Therapievorrichtung zur zelltherapie oder zellstimulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2020402573A1 true AU2020402573A1 (en) | 2022-07-07 |
Family
ID=68847951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2020402573A Pending AU2020402573A1 (en) | 2019-12-10 | 2020-12-11 | Therapeutic device for cell therapy or cell stimulation |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230012949A1 (de) |
| EP (1) | EP4072651B1 (de) |
| CN (1) | CN115209945A (de) |
| AU (1) | AU2020402573A1 (de) |
| CA (1) | CA3163067A1 (de) |
| DE (1) | DE112020006034A5 (de) |
| WO (1) | WO2021116358A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113995954A (zh) * | 2021-11-04 | 2022-02-01 | 东莞市安意科技有限公司 | 一种充电便携式高周波电疗仪 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH617590A5 (de) | 1977-05-27 | 1980-06-13 | Carba Ag | |
| US6866082B1 (en) | 1999-07-15 | 2005-03-15 | Zahner Design Group, Ltd. | Templates and kits for creation of hanging products |
| DE10324926B3 (de) * | 2003-06-03 | 2005-02-03 | Fachhochschule Hildesheim/Holzminden/Göttingen | Vorrichtung zur Behandlung eines lebende Zellen enthaltenden biologischen Materials mit einem durch eine Gasentladung erzeugten Plasma |
| MXPA05014141A (es) * | 2003-06-24 | 2006-03-09 | Healthonics Inc | Aparato y metodo para estimulo bioelectrico, aceleracion de sanado, alivio del dolor y desvitalizacion de patogeno. |
| DE102007030915A1 (de) | 2007-07-03 | 2009-01-22 | Cinogy Gmbh | Vorrichtung zur Behandlung von Oberflächen mit einem mittels einer Elektrode über ein Feststoff-Dielektrikum durch eine dielektrische behinderte Gasentladung erzeugten Plasma |
| DE102008045830A1 (de) | 2008-09-05 | 2010-03-11 | Cinogy Gmbh | Verfahren zur Behandlung eines lebende Zellen enthaltenden biologischen Materials |
| TW201141570A (en) | 2010-06-21 | 2011-12-01 | Yen-Lung Lin | Electromagnetic stimulation device and method thereof |
| WO2013042328A1 (ja) * | 2011-09-21 | 2013-03-28 | 株式会社Ｎｂｃメッシュテック | 低温プラズマと触媒体を用いるガス処理装置および方法 |
| US9173811B2 (en) * | 2011-09-29 | 2015-11-03 | Valencia Technologies Corporation | Implantable electroacupuncture system and method for treating depression and similar mental conditions |
| US20190117969A1 (en) * | 2017-10-23 | 2019-04-25 | Cardiac Pacemakers, Inc. | Medical devices for treatment of cancer with electric fields |
-
2020
- 2020-12-10 US US17/784,000 patent/US20230012949A1/en active Pending
- 2020-12-11 EP EP20820947.8A patent/EP4072651B1/de active Active
- 2020-12-11 AU AU2020402573A patent/AU2020402573A1/en active Pending
- 2020-12-11 CA CA3163067A patent/CA3163067A1/en active Pending
- 2020-12-11 WO PCT/EP2020/085655 patent/WO2021116358A1/de unknown
- 2020-12-11 DE DE112020006034.9T patent/DE112020006034A5/de active Pending
- 2020-12-11 CN CN202080085202.4A patent/CN115209945A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4072651C0 (de) | 2024-04-17 |
| CA3163067A1 (en) | 2021-06-17 |
| US20230012949A1 (en) | 2023-01-19 |
| WO2021116358A1 (de) | 2021-06-17 |
| EP4072651B1 (de) | 2024-04-17 |
| CN115209945A (zh) | 2022-10-18 |
| DE112020006034A5 (de) | 2022-10-06 |
| EP4072651A1 (de) | 2022-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Thana et al. | A compact pulse-modulation cold air plasma jet for the inactivation of chronic wound bacteria: Development and characterization | |
| Goree et al. | Killing of S. mutans bacteria using a plasma needle at atmospheric pressure | |
| Weltmann et al. | Atmospheric-pressure plasma sources: Prospective tools for plasma medicine | |
| US8896211B2 (en) | Physical means and methods for inducing regenerative effects on living tissues and fluids | |
| Sohbatzadeh et al. | Inactivation of Aspergillus flavus spores in a sealed package by cold plasma streamers | |
| KR101880852B1 (ko) | 대기압 플라즈마 장치 | |
| CN107430975A (zh) | 可变压力环境中的平衡阻挡放电中和 | |
| Kostov et al. | Study of cold atmospheric plasma jet at the end of flexible plastic tube for microbial decontamination | |
| US20210322945A1 (en) | Device and method for plasma activation of a liquid | |
| Li et al. | Study on plasma agent effect of a direct-current atmospheric pressure oxygen-plasma jet on inactivation of E. coli using bacterial mutants | |
| US20230012949A1 (en) | Therapeutic device for cell therapy or cell stimulation | |
| CA2883549A1 (en) | Apparatus and method for treating biological tissue using a low-pressure plasma | |
| Guimin et al. | Bacteria inactivation using DBD plasma jet in atmospheric pressure argon | |
| Xaubet et al. | Design optimization of an air atmospheric pressure plasma‐jet device intended for medical use | |
| KR101320291B1 (ko) | 국부소독 및 살균 가능한 핸드피스형 플라즈마 장치 | |
| Xia et al. | Discharge characteristics and bactericidal mechanism of Ar plasma jet with ethanol and oxygen gas admixtures | |
| Zhang et al. | Atmospheric-pressure air microplasma jets in aqueous media for the inactivation of Pseudomonas fluorescens cells | |
| Petrović et al. | Biomedical applications and diagnostics of atmospheric pressure plasma | |
| RU2638569C1 (ru) | Способ стерилизации газоразрядной плазмой атмосферного давления и устройство для его осуществления | |
| Xu et al. | A two-mode portable atmospheric pressure air plasma jet device for biomedical applications | |
| Kim et al. | Characterization of atmospheric pressure microplasma jet source and its application to bacterial inactivation | |
| Kieft | Plasma needle: exploring biomedical applications of non-thermal plasmas | |
| US20190328440A1 (en) | Micro-sized cold atmospheric plasma treatment | |
| Ivanova et al. | Comparison of biocidal and sporicidal effects of spark discharge plasma and mercury-vapor low pressure lamp radiations | |
| US20210015535A1 (en) | Cold Plasma Therapy Device with Replaceable Dielectric Barrier |